The rationale was explained at the AGM. mRNA vaccines or drugs induce inflammation courtesy of the TLR-7 receptor. Moderna and Pfizer/BioNTech have exclusive licence to the technology invented by the two recent Nobel Prize winners to help block the inflammatory response. All other companies interested in mRNA vaccines or drugs have been locked out of that technology and need to find another way to allow them onto the market. NOX believes that it has the only other way. So, I take it from that explanation that prospective Licensees are everyone else apart from Moderna and Pfizer/BioNTech.
- Forums
- ASX - By Stock
- NOX
- Ann: mRNA Vaccine Enhancer Shows Inflammation Reduction
Ann: mRNA Vaccine Enhancer Shows Inflammation Reduction, page-46
Featured News
Add NOX (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $23.37M |
Open | High | Low | Value | Volume |
8.2¢ | 8.2¢ | 8.0¢ | $5.491K | 68.10K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 147568 | 8.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.2¢ | 46145 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 147568 | 0.080 |
2 | 23624 | 0.071 |
1 | 10000 | 0.069 |
1 | 150000 | 0.066 |
1 | 100000 | 0.064 |
Price($) | Vol. | No. |
---|---|---|
0.082 | 46145 | 2 |
0.083 | 15965 | 1 |
0.089 | 93672 | 1 |
0.090 | 21000 | 2 |
0.091 | 10989 | 1 |
Last trade - 14.31pm 05/06/2024 (20 minute delay) ? |
|
|||||
Last
8.2¢ |
  |
Change
0.000 ( 5.13 %) |
|||
Open | High | Low | Volume | ||
8.2¢ | 8.2¢ | 8.2¢ | 30000 | ||
Last updated 11.56am 05/06/2024 ? |
Featured News
NOX (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO
Anthony Noble
CEO
Previous Video
Next Video
SPONSORED BY The Market Online